• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

Recent Advances in the Study of 5-methyl-1h-indazol-4-ol (CAS: 1360968-74-6) and Its Applications in Chemical Biology and Medicine

5-methyl-1h-indazol-4-ol (CAS: 1360968-74-6) has emerged as a compound of significant interest in the field of chemical biology and medicinal chemistry. Recent studies have highlighted its potential as a versatile scaffold for the development of novel therapeutic agents, particularly in the areas of oncology and inflammation. This research briefing provides an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications.

A recent study published in the Journal of Medicinal Chemistry explored the synthesis and optimization of 5-methyl-1h-indazol-4-ol derivatives for enhanced pharmacokinetic properties. The researchers employed a multi-step synthetic route, starting from commercially available precursors, to achieve high yields and purity of the target compound. The study also investigated the compound's stability under various physiological conditions, providing valuable insights for future formulation development.

In the context of biological activity, 5-methyl-1h-indazol-4-ol has shown promising results as an inhibitor of key signaling pathways involved in cancer progression. A 2023 study in Cancer Research demonstrated that this compound effectively targets the PI3K/AKT/mTOR pathway, leading to significant inhibition of tumor growth in preclinical models. The researchers noted that the compound's unique structural features contribute to its selectivity and potency, making it a promising candidate for further development.

Another area of active research involves the application of 5-methyl-1h-indazol-4-ol in inflammatory diseases. A recent publication in Nature Communications reported that derivatives of this compound exhibit potent anti-inflammatory effects by modulating NF-κB signaling. The study utilized both in vitro and in vivo models to validate the compound's efficacy, with results suggesting potential applications in conditions such as rheumatoid arthritis and inflammatory bowel disease.

From a drug development perspective, the physicochemical properties of 5-methyl-1h-indazol-4-ol have been extensively characterized. Computational modeling studies have predicted favorable drug-like properties, including good solubility and membrane permeability. These findings, combined with the compound's demonstrated biological activity, position it as a strong candidate for lead optimization programs in pharmaceutical research.

Looking ahead, several research groups are exploring the potential of 5-methyl-1h-indazol-4-ol as a building block for more complex drug molecules. Its structural flexibility allows for diverse modifications, enabling the creation of libraries of derivatives with tailored biological activities. This approach aligns with current trends in medicinal chemistry that emphasize the importance of scaffold diversity in drug discovery.

In conclusion, the growing body of research on 5-methyl-1h-indazol-4-ol (CAS: 1360968-74-6) underscores its significance in contemporary chemical biology and medicinal chemistry. The compound's unique properties and demonstrated biological activities make it a valuable subject for ongoing research, with potential applications spanning multiple therapeutic areas. Future studies will likely focus on further optimizing its pharmacological profile and exploring its mechanisms of action in greater detail.

• 1000343-61-2(5-Methoxy-6-methyl (1H)Indazole)
• 81382-45-8(1H-Indazol-4-ol)
• 23244-88-4(1H-Indazol-6-ol)
• 478841-61-1(5-Hydroxy-7-methyl-1H-indazole)
• 705927-36-2(4-Hydroxy-6-methyl-(1H)indazole)
• 1082042-15-6(5-Methyl-6-hydroxy-(1H)indazole)
• 478832-60-9(6-Methyl-1H-indazol-5-ol)
• 117070-73-2(4-methyl-1h-indazol-5-ol)
• 885522-40-7(4-Methoxy-6-methyl (1H)indazole)
• 885521-33-5(4-Methyl-1H-indazol-6-ol)